Place content here

Spotlight

Study shows longer-term CMV treatment effective for symptomatic babies

Kimberlin06small

David Kimberlin, MD,
Pediatric Infectious Diseases, and colleagues have published new findings in the New England Journal of Medicine of their study which evaluated shorter term (6 weeks) versus longer term (6 months) oral valganciclovir treatment for babies with symptomatic congenital cytomegalovirus (CMV) disease.  These findings build upon earlier studies Kimberlin's team conducted that established the dose to use, and showed that 6 weeks of treatment was better than no treatment.  The new study proved that treating for 6 months provides more durable improvement in hearing, as well as improvement in neurodevelopmental outcomes.  This is a major advance in the management of this infection, and adds to the decades of world leadership in congenital CMV research provided by the UAB Division of Pediatric Infectious Diseases.  Click here to read the article...  



Upcoming Events

Apr
1

12:00 pm-1:00 pm

Bradley Lecture Center, 1600 6th Ave S, Birmingham, AL 35233, United States

Apr
2

12:00 pm-1:00 pm

Bradley Lecture Center, 6th Avenue South, Birmingham, AL, United States

Apr
3

12:00 pm-1:00 pm

Children's Harbor Bradley Lecture Center, 1600 7th Avenue South

Apr
7

12:00 pm-1:00 pm

PCAMS Bldg 1924 7th Avenue South

Apr
9

12:00 pm-1:00 pm

Bradley Lecture Center, 6th Avenue South, Birmingham, AL, United States

Registration links for Pediatric Seminars